Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

5.0%

1 terminated out of 20 trials

Success Rate

93.8%

+7.2% vs benchmark

Late-Stage Pipeline

30%

6 trials in Phase 3/4

Results Transparency

53%

8 of 15 completed with results

Key Signals

8 with results94% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (6)
P 1 (2)
P 2 (3)
P 3 (3)
P 4 (3)

Trial Status

Completed15
Active Not Recruiting2
Unknown1
Terminated1
Withdrawn1

Trial Success Rate

93.8%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT03076918Not ApplicableCompletedPrimary

Evaluating the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy

NCT06135415Phase 3CompletedPrimary

A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis

NCT06014697Completed

OCT and Invasion in Cutaneous Skin Lesions

NCT05387525Phase 4Active Not RecruitingPrimary

A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp

NCT05060237Phase 1Completed

Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp

NCT05260073CompletedPrimary

Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis

NCT05636800Not ApplicableActive Not RecruitingPrimary

Microwave Treatment for Actinic Keratosis

NCT05279131Phase 3CompletedPrimary

A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis

NCT05356572Not ApplicableCompletedPrimary

A Pre-market Study to Evaluate the Performance and Safety of a Skin Preparation Device for Removal of Dry Crusty Skin

NCT04269395Phase 3TerminatedPrimary

A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study

NCT05481073CompletedPrimary

UV Sensor in Patients With Actinic Keratosis

NCT02813902Phase 1WithdrawnPrimary

A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors

NCT02594644Not ApplicableCompletedPrimary

The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy

NCT03697590Phase 4CompletedPrimary

Photodynamic Therapy of Actinic Keratosis of the Face and Scalp With and Without Prior Curettage

NCT03076892Not ApplicableCompletedPrimary

Evaluation of Non-inferiority and Tolerability of the Device PHOS-ISTOS

NCT02281682Phase 4UnknownPrimary

IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis

NCT02628236Phase 2CompletedPrimary

Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)

NCT02644187Not ApplicableCompleted

Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol

NCT02281136Phase 2CompletedPrimary

Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick

NCT01458587Phase 2CompletedPrimary

Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)

Showing all 20 trials

Research Network

Activity Timeline